From Biogen’s AdComm Meeting Will Test FDA’s “Substantial Evidence” Flexibility:

alzheimers-disease-neurons-with-amyloid-plaques-picture-id151645089

alzheimers-disease-neurons-with-amyloid-plaques-picture-id151645089—

Image: iStock/selvanegra
https://www.istockphoto.com/portfolio/selvanegra?assettype=image&mediatype=photography&sort=best

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

Sponsored · Webinar
Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins Discovery

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!